These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37698225)
1. A novel cuproptosis-related gene prognostic signature in colon adenocarcinoma. Su Y; Zhang K Can J Physiol Pharmacol; 2023 Nov; 101(11):589-598. PubMed ID: 37698225 [TBL] [Abstract][Full Text] [Related]
2. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Bian Z; Fan R; Xie L Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236 [TBL] [Abstract][Full Text] [Related]
3. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
4. The role of cuproptosis-related genes in pan-cancer and the development of cuproptosis-related risk model in colon adenocarcinoma. Li C; Zhu L; Liu Q; Peng M; Deng J; Fan Z; Duan X; Xue R; Guo Z; Lv X; Li L; Zhao J Heliyon; 2024 Jul; 10(14):e34011. PubMed ID: 39100456 [TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
6. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma. Zhou L; Zhang Y; Xu Y; Jiang T; Tang L Genes Genomics; 2023 Aug; 45(8):1047-1061. PubMed ID: 37318704 [TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617 [TBL] [Abstract][Full Text] [Related]
9. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD). Wang L; Cao Y; Guo W; Xu J J Cancer Res Clin Oncol; 2023 Jan; 149(1):15-24. PubMed ID: 36173462 [TBL] [Abstract][Full Text] [Related]
10. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170 [TBL] [Abstract][Full Text] [Related]
11. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma. Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497 [TBL] [Abstract][Full Text] [Related]
12. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia. Li Y; Kan X Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332 [TBL] [Abstract][Full Text] [Related]
13. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma. Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086 [TBL] [Abstract][Full Text] [Related]
14. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas. Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y Front Genet; 2022; 13():992995. PubMed ID: 36579333 [No Abstract] [Full Text] [Related]
15. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226 [TBL] [Abstract][Full Text] [Related]
16. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
17. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease. Liu L; Liang L; Yang C; Chen Y Front Immunol; 2023; 14():1136991. PubMed ID: 37275904 [TBL] [Abstract][Full Text] [Related]
18. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA. Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999 [No Abstract] [Full Text] [Related]
19. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Li Y; Zeng X Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728 [No Abstract] [Full Text] [Related]
20. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma. Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]